Oncorena Holding AB today announces that the company through a new share issue has secured capital to conduct clinical studies of a completely new treatment principle for kidney cancer. The capital has been raised from Oncorena’s current largest owner P.U.L.S. AB and through an investment by HealthCap. Furthermore, several wealthy private investors, including new as well as current shareholders in Oncorena, have contributed substantially.

read more